Lomerizine dihydrochloride is a relatively new L- and T-type calcium channel blocker used in the treatment of migraine.
Lomerizine dihydrochloride is a relatively new L- and T-type calcium channel blocker used in the treatment of migraine.
动物 A (mg/kg) = 动物 B (mg/kg)×动物 B的Km系数/动物 A的Km系数 | |
例如,已知某工具药用于小鼠的剂量为88 mg/kg , 则用于大鼠的剂量换算方法:将88 mg/kg 乘以小鼠的Km系数(3),再除以大鼠的Km系数(6),得到该药物用于大鼠的等效剂量44 mg/kg。
[1] Joe Aoyagi,et al. Alleviation of Brain Hypoperfusion after Preventative Treatment with Lomerizine in an Elderly Migraineur with Aura. Int J Mol Imaging. 2011; 2011: 782758. Published online 2010 Dec 27. doi: 10.1155/2011/782758.
[2] YUTA INOUE, TAKAO YABE. Lomerizine therapy for the treatment of benign paroxysmal vertigo of childhood transitioning into atypical basilar migraine: A case report. Exp Ther Med. 2013 Jun; 5(6): 1573–1575. Published online 2013 Apr 2. doi: 10.3892/etm.2013.1035.
分子式 C27H32Cl2F2N2O3 |
分子量 541.46 |
CAS号 101477-54-7, 101477-55-8(free base) |
储存方式 -20 ℃长期冷藏储存。冰袋运输 |
溶剂(常温) |
DMSO 100 mg/mL warmed |
Water <1 mg/mL |
Ethanol 52 mg/mL warmed |
体内溶解度
2% DMSO+ddH2O 5 mg/mL
注:以上所有数据均来自公开文献,并不保证对所有实验均有效,数据仅供参考。
相关化合物库
使用AMQUAR产品发表文献后请联系我们